Pharmaron Beijing Co Ltd Class A 300759

Morningstar Rating
CN¥40.54 −0.36 (0.88%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

300759 is trading at a LOCK|K@QqG premium.
Price
CN¥41.60
Fair Value
LOCK|.&T&vhZ
Uncertainty
LOCK|&!
1-Star Price
LOCK|.%fHmpx
5-Star Price
LOCK|.$z!V@>
Economic Moat
LOCK|^<^#
Capital Allocation
—

News

Trading Information

Previous Close Price
CN¥40.90
Day Range
CN¥40.43–41.25
52-Week Range
CN¥21.01–53.57
Bid/Ask
CN¥40.54 / CN¥40.55
Shares Outstanding
1.84B
Market Cap
CN¥75.48B
Volume/Avg
956,700 / 48M

Key Statistics

Price/Earnings (Normalized)
44.47
Price/Sales
4.65
Dividend Yield (Trailing)
0.49%
Dividend Yield (Forward)
0.49%
Dividend Payment Schedule
Jul
Total Yield
0.49%

Company Profile

Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Large Core
Total Number of Employees
25,088

Valuation

Metric
300759
Price/Earnings (Normalized)
44.47
Price/Book Value
4.45
Price/Sales
4.65
Price/Cash Flow
27.64
Price/Earnings
300759

Financial Strength

Metric
300759
Quick Ratio
0.69
Current Ratio
1.04
Interest Coverage
11.25
Quick Ratio
300759

Profitability

Metric
300759
Return on Assets (Normalized)
5.91%
Return on Equity (Normalized)
10.62%
Return on Invested Capital (Normalized)
7.70%
Return on Assets
300759

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Vertex Pharmaceuticals Inc
VRTX
LOCK|@#Q>YYLLOCK|VMMw$135B
Regeneron Pharmaceuticals Inc
REGN
LOCK|#T>>G%XLOCK|%Xf%H$99B
Moderna Inc
MRNA
LOCK|^l?FdFLOCK|kJ$84B
argenx SE ADR
ARGX
LOCK|t$vjFBwLOCK|#J$59B
BeOne Medicines Ltd ADR
ONC
LOCK|@^?r<KLOCK|Sb$48B
Royalty Pharma PLC Class A
RPRX
LOCK|@$d$<xc>LOCK|cd<#?$31B
Incyte Corp
INCY
LOCK|MQ$jDHLOCK|dR$24B
BioNTech SE ADR
BNTX
LOCK|#hXX#K@LOCK|j<C$21B
Alnylam Pharmaceuticals Inc
ALNY
LOCK|^>MX<b%LOCK|?nHC$21B
Jazz Pharmaceuticals PLC
JAZZ
LOCK|v#Sx>DLOCK|sv$15B

Sponsor Center